Responses to pomalidomide and placebo in myelofibrosis-related anaemia

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
LanguageEnglish
Pages532-533
Number of pages2
JournalLeukemia
Volume31
Issue number3
DOIs
Publication statusPublished - 1 Mar 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

@article{e246285cc7db4a19a17170490f4a86fd,
title = "Responses to pomalidomide and placebo in myelofibrosis-related anaemia",
author = "David Ross",
year = "2017",
month = "3",
day = "1",
doi = "10.1038/leu.2016.348",
language = "English",
volume = "31",
pages = "532--533",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "3",

}

Responses to pomalidomide and placebo in myelofibrosis-related anaemia. / Ross, David.

In: Leukemia, Vol. 31, No. 3, 01.03.2017, p. 532-533.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Responses to pomalidomide and placebo in myelofibrosis-related anaemia

AU - Ross, David

PY - 2017/3/1

Y1 - 2017/3/1

UR - http://www.scopus.com/inward/record.url?scp=85001764072&partnerID=8YFLogxK

U2 - 10.1038/leu.2016.348

DO - 10.1038/leu.2016.348

M3 - Comment/debate

VL - 31

SP - 532

EP - 533

JO - Leukemia

T2 - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 3

ER -